Fridays can be the most productive work day, as you look to shore up everything before the weekend starts.
Or, maybe instead, it’s a day filled with long lunches and listless Internet surfing, as you seek out all the interesting articles... Read more »
Biotech financing is a cyclical thing. Two years ago, the IPO window was unlatched but a number of companies ended up withdrawing their stock offerings. Others that pushed their IPOs through couldn’t sell shares at the price they wanted.
This year,... Read more »
Intel (NASDAQ: INTC) announced Thursday that CEO Brian Krzanich has resigned in the wake of the company’s recent discovery that he had been involved in a past consensual relationship with an Intel employee.
The relationship violated Intel’s non-fraternization policy—the finding... Read more »
The window for biotech IPOs remains wide open and six more companies have charged through it, raising more than $568 million in the span of 24 hours.
The first was Eidos Therapeutics (NASDAQ: EIDX), which raised $106 million in its... Read more »
CrowdStrike, a Silicon Valley cybersecurity company that fends off hackers by patrolling the edge devices connected to a network, announced today it raised $200 million in a financing round that sets the company’s valuation at more than $3 billion.
Sunnyvale,... Read more »
This week brought a sobering reminder of how far away we are from true gender equality in the life sciences. An industry party held during BIO’s annual meeting in Boston last week featured scantily clad women with company logos painted on... Read more »
Cassandra Trimnell has sickle cell disease. She also loves to travel. For her 30th birthday last year, she and her husband planned a trip to Indonesia, and she figured she would be fine. Growing up in Iowa, she was sick all... Read more »
Amazon is fundamentally disrupting how and where we shop, but in-store retail still has life in it.
The Seattle e-commerce giant is “a hefty competitor, but that doesn’t mean brands and retailers don’t have the ability to fight back,” says Kay... Read more »
Intel sealed its commitment to become a player in the burgeoning autonomous vehicle industry when it bought computer vision company Mobileye for more than $15 billion in 2017. The venerable Santa Clara, CA-based chipmaker is betting that its data analytics and... Read more »
Most of the cancer news this week happened at the massive ASCO meeting in Chicago. But not all, as we’ll see in a moment.
Also this week, Biogen and Eisai reported good news about an Alzheimer’s drug, but with plenty of... Read more »
The American Society of Clinical Oncology annual meeting, the world’s largest cancer conference, wraps up today in Chicago. Investors have dissected the data, picked winners and losers, and sent some biotech stocks soaring and others tumbling.
In the days before ASCO,... Read more »
Just 10 days to go—but it’s not too late to request your invitation to Xconomy’s most unique and thought-provoking event of the year: our annual Napa Summit: The Xconomy Retreat on Technology, Jobs, and Growth. We only have a few... Read more »